Expression of SATB1 promotes the growth and metastasis of colorectal cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhang, Yi ^a,b   Tian, Xiuyun ^a   Ji, Hong ^b   Guan, Xiaoya ^a   Xu, Wei ^a   Dong, Bin ^a   Zhao, Min ^a   Wei, Meng ^a   Ye, Chunxiang ^a   Sun, Yuan ^a   Yuan, Xiaosun ^a   Yang, Chen ^a   Hao, Chunyi ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b AEROSPACE CENTER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEAR PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 2; UNCLASSIFIED DRUG; MATRIX ATTACHMENT REGION BINDING PROTEIN; SATB1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL; CANCER GRADING; CELL CYCLE; CELL MOTION; COLORECTAL TUMOR; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ADULT; AGED; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; RNA, SMALL INTERFERING; TUMOR BURDEN;

EID: 84903549396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100413     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA: a cancer journal for clinicians 63: 11-30.
2. International Agency for Research on Cancer (IARC) website. Available: http://www-depiarcfr/. Accessed 2010.
3. Mahmoud N, Bullard Dunn K (2010) Metastasectomy for stage IV colorectal cancer. Diseases of the colon and rectum 53: 1080-1092.
4. Foster JH (1984) Treatment of metastatic disease of the liver: a skeptic's view. Seminars in liver disease 4: 170-179.
5. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T (1992) A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70: 631-645.
6. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, et al. (2000) The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes & development 14: 521-535. (Pubitemid 30159772)
7. Ahlfors H, Limaye A, Elo LL, Tuomela S, Burute M, et al. (2010) SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation. Blood 116: 1443-1453.
8. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, et al. (2010) Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS biology 8: e1000296.
9. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nature genetics 34: 42-51. (Pubitemid 36548789)
10. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645.
11. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193. (Pubitemid 351380252)
12. Zhao XD, Ji WY, Zhang W, He LX, Yang J, et al. (2010) Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL; journal for oto-rhinolaryngology and its related specialties 72: 1-5.
13. Cheng C, Lu X, Wang G, Zheng L, Shu X, et al. (2010) Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 118: 855-863.
14. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, et al. (2010) SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncology reports 24: 981-987.
15. Chen H, Takahara M, Oba J, Xie L, Chiba T, et al. (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. Journal of dermatological science 64: 39-44.
16. Xu L, Deng HX, Xia JH, Yang Y, Fan CH, et al. (1997) Assignment of SATB1 to human chromosome band 3p23 by in situ hybridization. Cytogenetics and cell genetics 77: 205-206. (Pubitemid 27370929)
17. Naito T, Tanaka H, Naoe Y, Taniuchi I (2011) Transcriptional control of T-cell development. International immunology 23: 661-668.
18. Burute M, Gottimukkala K, Galande S (2012) Chromatin organizer SATB1 is an important determinant of T-cell differentiation. Immunology and cell biology 90: 852-859.
19. Nie H, Maika SD, Tucker PW, Gottlieb PD (2005) A role for SATB1, a nuclear matrix association region-binding protein, in the development of CD8SP thymocytes and peripheral T lymphocytes. Journal of immunology 174: 4745-4752.
20. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, et al. (2012) Correlation of SATB1 overexpression with the progression of human rectal cancer. International journal of colorectal disease 27: 143-150.
21. Nodin B, Johannesson H, Wangefjord S, O'Connor DP, Lindquist KE, et al. (2012) Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagnostic pathology 7: 115.
22. Zhang J, Zhang B, Zhang X, Sun Y, Wei X, et al. (2013) SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PloS one 8: e47902.
23. Fang XF, Hou ZB, Dai XZ, Chen C, Ge J, et al. (2013) Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. World journal of gastroenterology: WJG 19: 2331-2339.
24. Boye K, Maelandsmo GM (2010) S100A4 and metastasis: a small actor playing many roles. The American journal of pathology 176: 528-535.
25. Garrett SC, Varney KM, Weber DJ, Bresnick AR (2006) S100A4, a mediator of metastasis. The Journal of biological chemistry 281: 677-680.
26. Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, et al. (1998) Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 95: 11709-11714. (Pubitemid 28460479)
27. Zhang F, Tang Z, Hou X, Lennartsson J, Li Y, et al. (2009) VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 106: 6152-6157.
28. Salven P, Lymboussaki A, Heikkila P, Jaaskela-Saari H, Enholm B, et al. (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. The American journal of pathology 153: 103-108. (Pubitemid 28317512)
29. Chang C, Werb Z (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in cell biology 11: S37-43.
30. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
31. Darrington E, Zhong M, Vo BH, Khan SA (2012) Vascular endothelial growth factor A, secreted in response to transforming growth factor-beta1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells. Asian journal of andrology 14: 745-751.
32. NCBI website. Available: http://www.ncbi.nlm.nih.gov/books/NBK5330. Latest update: January 2013.
33. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, et al. (1992) Transforming growth factor-beta. Cancer surveys 12: 81-103.
34. Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, et al. (2011) Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo. Chinese medical journal 124: 3794-3799.
35. Qi W, Twigg S, Chen X, Polhill TS, Poronnik P, et al. (2005) Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. American journal of physiology Renal physiology 288: F800-809. (Pubitemid 40381749)
36. Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. Journal of cell science 119: 4803-4810. (Pubitemid 46017793)
37. Berx G, Van Roy F (2001) The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast cancer research: BCR 3: 289-293. (Pubitemid 32851157)
38. Potter E, Bergwitz C, Brabant G (1999) The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocrine reviews 20: 207-239. (Pubitemid 29339591)
39. Meng WJ, Yan H, Li Y, Zhou ZG (2011) SATB1 and colorectal cancer in Wnt/beta-catenin signaling: Is there a functional link? Medical hypotheses 76: 277-279.
40. Dobreva G, Dambacher J, Grosschedl R (2003) SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes & development 17: 3048-3061. (Pubitemid 38040769)
41. Eberhard J, Gaber A, Wangefjord S, Nodin B, Uhlen M, et al. (2012) A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. British journal of cancer 106: 931-938.
42. Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, et al. (2009) Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. The Journal of pathology 219: 114-122.